Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition treating fatty liver and preparations thereof

A technology of composition and fatty liver, which is applied in the direction of drug combination, medical preparations containing active ingredients, pharmaceutical formulas, etc., and can solve problems such as long treatment course, many adverse reactions, and insufficient patient compliance

Active Publication Date: 2012-10-17
ZHANGZHOU PIEN TZE HUANG PHARM
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the intervention of reasonable diet, alcohol prohibition and increased exercise is more effective in the treatment of fatty liver, but the patient's compliance is not enough
Clinically, there is still a lack of anti-fatty liver drugs with ideal curative effect. Although the reported drugs such as cholestyramine, inositol nicotinate, bezafibrate, and gemfibrozil can inhibit fatty liver from different links, their adverse reactions Many, long course of treatment, so the clinical application is limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition treating fatty liver and preparations thereof
  • Medicinal composition treating fatty liver and preparations thereof
  • Medicinal composition treating fatty liver and preparations thereof

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0040] Experimental example 1 Comparative test of the drug effect of the composition preparation of the present invention on experimental fatty liver in rats

[0041] 1. Experimental purpose: to observe the effect of the composition preparation of the present invention on the rat fatty liver (FLD) model, and to provide a pharmacodynamic experiment basis for the composition preparation of the present invention to prevent and treat fatty liver.

[0042] 2. Experimental materials:

[0043] (1) Experimental animals: clean grade white rats, SD, ♂, 120-140g, 110, certificate of conformity: 0023665, Shanghai Slack Experimental Animal Co., Ltd.

[0044] (2) Test drugs:

[0045] Composition tablet of the present invention (trade name: Pien Tze Huang Ganbao, prepared according to the method in Example 1): unprepared raw powder, in yellowish brown granules, containing 2.916g of crude drug per gram, batch number: 0608001. Prepared with distilled water during the test.

[0046] (3) Oth...

Embodiment 1

[0127] Embodiment 1 tablet of the present invention

[0128] Formula: capillary 150g, gentian 120g, gardenia 50g, rhubarb 10g, white peony 30g, licorice 30g, notoginseng 42.5g, snake gallbladder 3.5g, bezoar 2.5g, artificial musk 1.5g.

[0129] Preparation method:

[0130] A. Take rhubarb, white peony root and notoginseng and grind them into fine powder 1, take snake gallbladder, bezoar and artificial musk and grind them into fine powder 2,

[0131] B. Take capillary, gentian, gardenia, licorice and other four medicinal materials and add water to extract twice, each time for 2 hours (8 times the amount in the first time, 6 times the amount in the second time), filter, and concentrate the filtrate to The relative density is 1.200-1.230 (heat measurement 40°C-50°C), add ethanol to make the alcohol content of the liquid reach 70%, let it stand, take the supernatant, recover the ethanol and continue to concentrate until the relative density is 1.25-1.30 (heat Measure the thick...

Embodiment 2

[0134] Embodiment 2 powder of the present invention

[0135] Formula: capillary 60g, gentian 190g, gardenia 18g, rhubarb 16g, white peony root 12g, licorice 48g, notoginseng 15g, snake gallbladder 6g, bezoar 1g, artificial musk 2.5g.

[0136] The above-mentioned medicine is added into conventional auxiliary materials, and according to the conventional process, it is made into a powder, each serving 1g, three times a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal composition treating fatty liver and preparations thereof. The composition consists of the following bulk medicines by weight: 50-250 parts of capillary artemisia, 40-200 parts of Chinese gentian, 15-85 parts of Gardenia jasminoides Ellis, 3-18 parts of rheum officinale, 10-50 parts of white paeony roots, 10-50 parts of licorice, 14-70 parts of Panax notoginseng, 1-6 parts of snake gall, 1-4 parts of calculus bovis, and 0.5-2.5 parts of artificial musk. Conventional accessories are added into the bulk medicines to prepare various clinically acceptable preparations according to conventional technologies. The invention also discloses application of the medicinal composition in preparing medicines treating fatty liver.

Description

technical field [0001] The invention relates to a pharmaceutical composition and its preparation, preparation method and quality detection method, in particular to a pharmaceutical composition for treating fatty liver and its preparation, preparation method and quality detection method, belonging to the technical field of pharmacy. Background technique [0002] In recent years, with the continuous improvement of people's living standards and changes in dietary structure, the incidence of fatty liver has shown an obvious upward trend. The pathogenesis of fatty liver is mainly related to abnormal liver lipid metabolism, obesity, long-term heavy drinking, diabetes, viral hepatitis, etc., and can gradually develop into end-stage liver diseases such as liver cirrhosis and liver cancer. At present, the intervention of reasonable diet, alcohol prohibition, and increased exercise is more effective in the treatment of fatty liver, but the patient's compliance is not enough. Clinical...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/744A61P1/16
Inventor 潘杰黄进明洪绯
Owner ZHANGZHOU PIEN TZE HUANG PHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com